GLUCAGON ANTAGONISTS - A TOOL FOR THE TREATMENT OF TYPE-II DIABETES

被引：0
|
作者：
HUTZLER, AM [1 ]
AZIZEH, BY [1 ]
STURM, NS [1 ]
DAVID, CS [1 ]
VANTINE, RA [1 ]
TRIVED, D [1 ]
HRUBY, VJ [1 ]
机构：
[1] UNIV GEORGIA,DEPT CHEM,ATHENS,GA 30602
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：199 / MEDI
相关论文
共 50 条
  • [11] GLUCAGON TEST - AN INDEX OF INSULINIZATION IN TYPE-II DIABETES-MELLITUS
    PEIG, M
    COVES, MJ
    CASAMITJANA, R
    SORIANO, G
    GUILLEN, M
    FIGUEROLA, D
    MEDICINA CLINICA, 1985, 85 (14): : 568 - 570
  • [12] MAIN POINTS IN THE TREATMENT OF DIABETES TYPE-II
    SCHOFFLING, K
    MEDIZINISCHE WELT, 1986, 37 (32-33): : 1007 - 1012
  • [13] Novel indazole-/indole-based glucagon receptor antagonists for treatment of type II diabetes
    Lin, Songnian
    Zhang, Fengqi
    Jiang, Guoqiang
    Qureshi, Sajjad A.
    Yang, Xiaodong
    Chicchi, Gary G.
    Tota, Laurie
    Bansal, Alka
    Brady, Edward
    Trujillo, Maria
    Salituro, Gino
    Miller, Corey
    Tata, James R.
    Zhang, Bei B.
    Parmee, Emma
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [14] Discovery of potent glucagon receptor antagonists for the treatment of type 2 diabetes
    Xu, Guozhang
    Gaul, Michael
    Song, Fengbin
    Zhao, Baoping
    Liang, Yin
    Du, Fuyong
    Diloreto, Karen
    Huebert, Norman
    Shook, Brian
    Rentzeperis, Dennis
    Santulli, Rosemary
    Eckardt, Annette
    Smith, Charles
    Demarest, Keith
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [15] DIABETES, TYPE-II
    HAMILTON, EA
    NUTRITION TODAY, 1983, 18 (02) : 36 - 37
  • [16] TYPE-II DIABETES
    INGENABEL, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (19) : 704 - 704
  • [17] ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE-II DIABETES
    TAL, A
    AMERICAN FAMILY PHYSICIAN, 1993, 48 (06) : 1089 - 1095
  • [18] TYPE-II DIABETES - SOME PROBLEMS IN DIAGNOSIS AND TREATMENT
    SIPERSTEIN, MD
    HOSPITAL PRACTICE, 1985, 20 (03): : 55 - 63
  • [19] SULFONYLUREA COMPOUNDS OR BIGUANIDES IN THE TREATMENT OF TYPE-II DIABETES
    MEHNERT, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (27) : 1086 - 1088
  • [20] ORAL SULFONYLUREAS FOR THE TREATMENT OF TYPE-II DIABETES - AN UPDATE
    SHANK, WA
    MORRISON, AD
    SOUTHERN MEDICAL JOURNAL, 1986, 79 (03) : 337 - 343
12345